Alternative pathways for T lymphocyte activation.
Shevach
E M
EM
Laboratory of Immunology, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland 20892.
D000818:Animals; D000911:Antibodies, Monoclonal / Q000276:immunology / Q000627:therapeutic use; D000945:Antigens, Differentiation, T-Lymphocyte / Q000276:immunology; D000950:Antigens, Ly / Q000276:immunology*; D000954:Antigens, Surface / Q000276:immunology*; D002051:Burkitt Lymphoma; D008213:Lymphocyte Activation; D051379:Mice; D008954:Models, Biological; D009374:Neoplasms, Experimental / Q000628:therapy; D011948:Receptors, Antigen, T-Cell / Q000276:immunology; D015398:Signal Transduction; D013601:T-Lymphocytes / Q000276:immunology*; D018800:Thy-1 Antigens; D014407:Tumor Cells, Cultured
D000911:Antibodies, Monoclonal; D000945:Antigens, Differentiation, T-Lymphocyte; D000950:Antigens, Ly; D000954:Antigens, Surface; D011948:Receptors, Antigen, T-Cell; D018800:Thy-1 Antigens